Risperdal More than Doubles Risk of Adverse Events for People with Dementia. Therefore, Keep People with Dementia on Risperdal. Wait . . . what?
by Anthony Chicotel, CANHR Staff Attorney A new study in the October 18, 2012 issue of the venerable New England Journal of Medicine assesses the efficacy of drugging dementia patients with Risperdal versus abruptly discontinuing the drug and substituting a … Continue reading
Last month, Thomas Szasz, a long-time critic of American mental health treatment passed away. While Szasz was a controversial figure, particularly among his fellow psychiatrists, his stance against medicalizing vexing behavior as an illness or disease to be eradicated with … Continue reading
This month’s issue of Provider Magazine follows up on its July issue to tout non-drugging alternatives for resolving behavioral problems for people with dementia. The feature article describes a new paradigm for good dementia care, focused on understanding what a … Continue reading
by Michael Connors, CANHR Advocate According to a new report by the British government, the number of people with dementia who are being given antipsychotics dropped by more than half (52 percent) between 2008 and 2011. The remarkable findings are … Continue reading
by Anthony Chicotel, CANHR Staff Attorney McKnight’s, a magazine and provider of long-term care news and commentary, recently posted a Daily Editor’s Blog article from John O’Connor, decrying the increased federal focus on the misuse of antipsychotics as a front-line … Continue reading
The July 2012 issue of Provider, a magazine published by the American Health Care Association and the National Center for Assisted Living, has a cover story on finding alternatives to antipsychotics for long-term care facility residents with dementia. The article … Continue reading
by Anthony Chicotel, CANHR Staff Attorney With a decent amount of fanfare, the Center for Medicare and Medicaid Services (CMS) and the nursing home trade group American Health Care Association (AHCA) recently announced an initiative to reduce the unnecessary use … Continue reading
Every Resident Left Behind? OIG finds 99% of residents on antipsychotics have federally deficient care plans.
by Michael Connors, CANHR Advocate This week, the HHS Office of Inspector General (OIG) issued another stunning report on the rampant misuse of antipsychotic drugs in our nation’s nursing homes. According to the OIG, nearly every nursing home record it … Continue reading
by Anthony Chicotel, CANHR Staff Attorney In a conference call with reporters, David Gifford, MD, senior vice president of quality and regulatory affairs for the American Health Care Association (AHCA) stated “we believe these antipsychotic medications are overprescribed.” He added “while … Continue reading
by Anthony Chicotel, CANHR Staff Attorney In early 2011, DPH issued AFL 11-08 to clarify that its informed consent rules for psychotropic drugs in nursing homes applied to drugs that were prescribed prior to the resident’s admission.* The purpose of … Continue reading